Recurrent Depression
7
3
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Psilocybin rTMS for Treatment Resistant Depression
Neuro-computational Study of Thymic Fluctuations in Mood Disorders
OSU6162 as add-on in SSRI/SNRI-resistant Depression
Mindfulness Based Compassionate Living in Recurrent Depression
Rumination Focused Cognitive Behavioral Therapy for Major Depression and Recurrent Depression
Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression
Implementation and Evaluation of "Mindfulness-Based Cognitive Therapy" in a Health Care Region in Flanders: a Randomized Clinical Trial